Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

NKTRNKTR
4 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in Nektar Therapeutics

DEUTSCHE BANK AG\ holds 239,831 shares of NKTR (Nektar Therapeutics), worth $16.7M as of 2026-Q2. The position was increased (+161.6% shares). NKTR represents 0.0% of DEUTSCHE BANK AG\'s portfolio.

Current Value

$16.7M

Current Shares

239,831

Total Value Change

+$11.6M

Total Shares Change

+149,831

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
239,831
+161.6%
$16.7M0.0%$69.81
46
2026-Q1
Increased
91,671
+1.0%
$6.6M0.0%$68.11
27
2025-Q4
Increased
90,743
+0.8%
$3.8M0.0%$41.90
27
2025-Q3
New
90,000
-
$5.1M0.0%$58.92
37

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used